397
Views
6
CrossRef citations to date
0
Altmetric
Miscellaneous

Contrast-Medium-Induced Nephropathy Correlated to the Ratio Between Dose in Gram Iodine and Estimated GFR in ml/min

, , , , &
Pages 830-842 | Accepted 01 Sep 2005, Published online: 09 Jul 2009

References

  • Ahn S. S., Obrand D. I. Contrast agents. Handbook of endovascular surgery, 1st edn. Karger Landes System Basel. 1997; 9–12
  • Allaqaband S., Tumuluri R., Malik A. M., Gupta A., Volkert P., Shalev Y., et al. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc Interv 2002; 57: 279–83
  • Aspelin P., Almén T. Studies of the acute toxicity of ionic and non-ionic contrast media following rapid intravenous injection. Invest Radiol 1976; 11: 309–14
  • Aspelin P., Aubry P., Fransson S. G., Strasser R., Willenbrock R., Berg K. J. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003; 348: 491–9
  • Awai K., Hori S. Effect of contrast injection protocol with dose tailored to patient weight and fixed injection duration on aortic and hepatic enhancement at multidetector-row helical CT. Eur Radiol 2003; 13: 2155–60
  • Awai K., Hiraishi K., Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dynamic CT involving injection protocol with dose tailored to patient weight. Radiology 2004; 230: 142–50
  • Barrett B. J., Carlisle E. J. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188: 171–8
  • Bernstein E. F., Palmer J. D., Aaberg T. A., Davis R. L. Studies of the toxocity of Hypaque-90 per cent following rapid intravenous injection. Radiology 1961; 76: 88–95
  • Bostom A. G., Kronenberg F., Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol 2002; 13: 2140–4
  • Briguori C., Manganelli F., Scarpato P., Elia P. P., Golia B., Riviezzo G., et al. Acetylcysteine and contrast agent-associated nephrotoxicity. J Am Coll Cardiol 2002; 40: 298–303
  • Choyke P. L., Cady J., DePollar S. L., Austin H. Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?. Tech Urol 1998; 4: 65–9
  • Cigarroa R. G., Lange R. A., Williams R. H., Hillis L. D. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 1989; 86: 649–52
  • Cockcroft D. W., Gault M. H. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31–41
  • Davidson C. J., Hllatky M., Morris K. G., Pieper K., Skelton T. N., Schwab S. J., et al. Cardiovascular and renal toxicity of a non-ionic radiographic contrast agent after cardiac catheterization. A prospective trial. Ann Int Med 1989; 110: 119–24
  • Duncan L., Heathcote J., Djurdjev O., Levin A. Screening for renal disease using serum creatinine: who are we missing?. Nephrol Dial Transplant 2001; 16: 1042–6
  • Farinas P. L. A new technique for the arteriographic examination of the abdominal aorta and its branches. Am J Roentgenol 1941; 46: 641–5
  • Frank H., Werner D., Lorusso V., Klinghammer L., Daniel W. G., Kunzendorf U., et al. Simultaneous hemodialysis during coronary angiography fails to prevent radiocontrast-induced nephropathy in chronic renal failure. Clin Nephrol 2003; 60: 176–82
  • Freeman R. V., O'Donnell M., Share D., Meengs W. L., Kline-Rogers E., Clark V. L., et al. Blue Cross–Blue Shield of Michigan Cardiovascular Consortium (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 90: 1068–73
  • Gault M. H., Longerich L. L., Harnett J. D., Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992; 62: 249–56
  • Garcia-Ruiz C., Martinez-Vea A., Sempere T., Sauri A., Olona M., Peralta C., et al. Low risk of contrast nephropathy in high-risk patients undergoing spiral computed tomography angiography with the contrast medium iopromide and prophylactic oral hydratation. Clin Nephrol 2004; 61: 170–6
  • Gleeson T. G., Bulugahapitiya S. Contrast-induced nephropathy. Am J Roentgenol 2004; 183: 1673–89
  • Gruberg L., Mintz G. S., Mehran R., Gangas G., Lansky A. J., Kent K. M., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 2000; 36: 1542–8
  • Gruberg L., Mehran R., Dangas G., Mintz G. S., Waksman R., Kent K. M., et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001; 52: 409–16
  • Gruberg L., Dangas G., Mehran R., Mintz G. S., Kent K. M., Pichard A. D., et al. Clinical outcome following percutaneous coronary interventions in patients with chronic renal failure. Catheter Cardiovasc Interv 2002; 55: 66–72
  • Holmquist F., Nyman U. 80-kVp multislice CT of pulmonary arteries (msCTPA) to minimize contrast medium (CM) doses to diagnose pulmonary embolism (PE) in patients with decreased renal function. Eur Radiol 2005; 15(Suppl 1)268
  • Hu K. T., Matayoshi A., Stevenson F. T. Calculation of the estimated creatinine clearance in avoiding drug dosing errors in the older patient. Am J Med Sci 2001; 322: 133–6
  • Huda W., Scaletti E. M., Levin G. Technique factors and image quality as function of patient weight at abdominal CT. Radiology 2000; 217: 430–5
  • Hull J. H., Hak L. J., Koch G. G., Wargin W. A., Chi S. L., Mattocks A. M. Influence of range of renal function and liver disease on predictability of creatinine clearance. Clin Pharmacol Ther 1981; 29: 516–21
  • Kay J., Chow W. H., Chan T. M., Lo S. K., Kwok O. H., Yip A., et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003; 289: 553–8
  • Kolehmainen H., Soiva M. Comparison of Xenetix 300 and Visipaque 320 in patients with renal failure (P27). 10th European Symposium on Urogenital Radiology. Eur Radiol 2003; 13: B32–3
  • Levey A. S., Grene T., Kusek J. W., Beck G. J. A simplified equation to predict glomerular filtration rate from serum creatinine (Abstract). J Am Soc Nephrol 2000; 11: A0828
  • Liistro F., Falsini G., Bolognese L. The clinical burden of contrast media-induced nephropathy. Ital Heart J 2003; 4: 668–76
  • Lott R. S., Hayton W. L. Estimation of creatinine clearance from serum creatinine concentration. A review. Drug Intell Clin Pharm 1978; 12: 140–50
  • Lufft V., Hoogestraat-Lufft L., Fels L. M., Egbeyong-Baiyee D., Tusch G., Galanski M., et al. Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 2002; 40: 236–42
  • Manjunath G., Sarnak M. J., Levey A. S. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 2001; 10: 785–92
  • Marenzi G., Marana I., Lauri G., Assanelli E., Grazi M., Campodonico J., et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003; 349: 1333–40
  • Marenzi G., Lauri G., Assanelli E., Campodonico J., De Metrio M., Marana I., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780–5
  • McCullough P. A., Wolyn R., Rocker L. L., Levin R. N., O'Neill W. W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368–75
  • McCullough P. A. Beyond serum creatinine: defining the patient with renal insufficiency and why?. Rev Cardiovasc Med 2003; 4(Suppl 1)S2–6
  • Morcos S. K., Thomsen H. S., Webb J. A. W. Contrast media induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602–13
  • Morcos S. K. Contrast medium-induced nephrotoxicity. Textbook of contrast media, P Dawson, D. O Cosgrove, R. G Grainger. Isis Medical Media Ltd, Oxford 1999; 135–48, In
  • Morcos S. K. Prevention of contrast media nephrotoxicity – the story so far. Clin Radiol 2004; 59: 381–9
  • Mueller C., Buerkle G., Buettner H. J., Petersen J., Perruchoud A. P., Eriksson U., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329–36
  • Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930–6
  • National Kidney Foundation. National Kidney Foundation guidelines for chronic kidney disease: evaluation, classification, and stratification., Am J Kidney Dis. 2. S46–110
  • Nikolsky E., Aymong E. D., Dangas G., Mehran R. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function. Rev Cardiovasc Med 2003; 4(Suppl 1)S7–14
  • Nyman U. An obscure formula in case of renal dysfunction. J Vasc Interv Radiol 2000; 11: 668
  • Nyman U., Hietala S. O., Hellström M., Aspelin P., Björkdahl P., Albrechtsson U., et al. Iodinated contrast media and nephropathy – new recommendations. Estimated creatinine clearance for better assessment of renal function and dosage (Swedish). Läkartidningen 2003; 100: 840–8
  • Perrone R. D., Madias N. E., Levey A. S. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 1992; 38: 1933–53
  • Rich M. W., Crecelius C. A. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150: 1237–42
  • Rihal C. S., Textor S. C., Grill D. E., Berger P. B., Ting H. H., Best P. J., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary interventions. Circulation 2002; 105: 2259–64
  • Rudnick M. R., Goldfarb S., Wexler L., Ludbrook P. A., Murphy M. J., Halpern E. F., et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254–61
  • Sawyer W. T., Canaday B. R., Poe T. E., Webb C. E., Porter R. S., Gal D. P., et al. A multicenter evaluation of variables affecting the predictability of creatinine clearance. Am J Clin Pathol 1982; 78: 832–8
  • Shemesh O., Golbetz H., Kriiss J. P., Myers B. D. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985; 28: 830–8
  • Shyu K. G., Cheng J. J., Kuan P. Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002; 40: 1383–8
  • Stacul F, Bertrand ME, McCullough PA, Brinker JA. Contrast-induced nephropathy (CIN) following iso-osmolar (IOCM) versus low-osmolar contrast media (LOCM) in patients undergoing angiography and predicting factors for CIN: A meta-analysis of prospective trials. European Congress of Radiology, Online abstract www.ecr.org, Vienna; March 2004
  • Sterner G., Wroblewski M., Rosén U. Postprandial increase in serum creatinine in renal transplant recipients. Transpl Int 1992; 5: 115–17
  • Sterner G., Nyman U., Valdes T. Low risk of contrast medium induced nephropathy with modern angiographic technique. J Int Med 2001; 250: 429–34
  • Stevens M. A., McCullough P. A., Tobin K. J., Speck J. P., Westveer D. C., Guido-Allen D. A., et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. J Am Coll Cardiol 1999; 33: 403–11
  • Tepel M., van der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000; 343: 180–4
  • Thomsen H. S. Guidelines for contrast media from the European Society of Urogenital Radiology. Am J Roentgenol 2003; 181: 1463–71
  • Tippins R. B., Torres W. E., Baumgartner B. R., Baumgarten D. A. Are screening serum creatinine levels necessary prior to outpatient CT examinations?. Radiology 2000; 216: 481–4
  • Trivedi H. S., Moore H., Nasr S., Aggarwal K., Agrawal A., Goel P., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 93: C29–34
  • Waybill M. M., Waybill P. N. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J Vasc Interv Radiol 2001; 12: 3–9
  • Vlietstra R. E., Nunn C. M., Narvarte J., Browne K. F. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 1996; 1049–50, 132

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.